Cargando…
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
Background: Patients with locally advanced rectal cancer are treated with preoperative chemoradiotherapy followed by surgical resection. Despite similar clinical parameters (uT2-3, uN+) and standard therapy, patients’ prognoses differ widely. A possible prediction of prognosis through microRNAs as b...
Autores principales: | Azizian, Azadeh, Epping, Ingo, Kramer, Frank, Jo, Peter, Bernhardt, Markus, Kitz, Julia, Salinas, Gabriela, Wolff, Hendrik A., Grade, Marian, Beißbarth, Tim, Ghadimi, B. Michael, Gaedcke, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849024/ https://www.ncbi.nlm.nih.gov/pubmed/27092493 http://dx.doi.org/10.3390/ijms17040568 |
Ejemplares similares
-
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017) -
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy
por: Emons, Georg, et al.
Publicado: (2022) -
Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016) -
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016) -
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
por: Jo, Peter, et al.
Publicado: (2020)